01-01-1970 12:00 AM | Source: Reuters
India's Serum Institute takes 50% stake in drug vial maker Schott Kaisha
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
BENGALURU - Serum Institute of India, the world's largest vaccine maker by production volume, has taken a 50% stake in Indian drug vial maker Schott Kaisha, the companies said in a statement https://bit.ly/3AIBLvS on Tuesday.
Serum Institute was already a customer of Schott Kaisha, using their vials, ampoules and syringes to store vaccines including the COVID-19 vaccine Covishield. The companies did not provide any further details on the deal.
Latest News
Buy Apollo Pipes Ltd or Target Rs. 276 By Yes Secur...
Renowned Musician Avadhoot Gupte Acquires Rs. 7.7 Cr...
C/D Ratio Nudges Downwards as Credit Offtake Moderat...
US Elections 2024: Limited Impact Expected on Indian...
Buy Godawari Power & Ispat Ltd or Target Rs. 276 By...
Views on Effect of US Elections on Indian Markets by...
HCLFoundation and UP Government Sign MoU to enhance ...
Quote on Markets By Vikram Kasat, Head - Advisory, P...
Qlik Opens Registration for Qlik Connect 2025, Its A...
Dr Reddy's Laboratories Ltd. Q2FY25 Result First Cut...
